1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsTSET Legacy Grants is sponsored by Tobacco Settlement Endowment Trust. Supports large-scale, multi-year projects aimed at preventing disease and enhancing quality of life in Oklahoma, particularly in rural and underserved communities.
Get alerted about grants like this
Get emailed when new opportunities from “Tobacco Settlement Endowment Trust” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The TSET Legacy Grant is a one-time, historic funding opportunity designed to address Oklahoma’s leading causes of death — cancer and cardiovascular disease. With an investment of up to $150 million, TSET is funding large-scale, transformational projects that will improve rural health, health care access, prevention and data-driven solutions across the state.
</p>\n<p>The TSET Legacy Grant is more than just funding — it’s an investment in Oklahoma’s future. By supporting projects that tackle the root causes of chronic disease, we are helping to build a healthier, stronger state for generations to come. </p>\n<p>This initiative will have broad, lasting impact, particularly in rural and underserved communities, and will help drive data-informed solutions to improve health outcomes statewide.
</p>\n"}}" id="text-3f95874ae3" class="cmp-text"> The TSET Legacy Grant is a one-time, historic funding opportunity designed to address Oklahoma’s leading causes of death — cancer and cardiovascular disease. With an investment of up to $150 million, TSET is funding large-scale, transformational projects that will improve rural health, health care access, prevention and data-driven solutions across the state.
The TSET Legacy Grant is more than just funding — it’s an investment in Oklahoma’s future. By supporting projects that tackle the root causes of chronic disease, we are helping to build a healthier, stronger state for generations to come. This initiative will have broad, lasting impact, particularly in rural and underserved communities, and will help drive data-informed solutions to improve health outcomes statewide.
Tobacco Settlement Endowment Trust 2800 N. Lincoln Blvd. , Suite 202 Oklahoma Tobacco Helpline
According to the current listing, eligibility includes: Public institutions, public entities, state agencies, 501(c)(3) nonprofits, and tribal entities in Oklahoma. Confirm the full requirements in the official notice before applying.
The current listing shows up to $150 million. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 16, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
TSET Legacy Grants is funded by Tobacco Settlement Endowment Trust. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Oklahoma. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
After court settlements with state attorneys general and the ACLU, NIH is re-reviewing more than 5,000 previously frozen or denied grant applications. What happened, who is affected, and what to do next.
Read articleBuried in the §200.340 termination provisions of the May 29 Uniform Grants Regulation rewrite is a fundamental restructuring of federal grant termination law. The new rule explicitly models grant termination on the Federal Acquisition Regulation's termination-for-convenience framework — agencies may terminate when termination is in the agency's interest, when an award no longer advances agency priorities, or when the national interest as it exists at the time of termination has shifted. Unlike federal contracts, the rule eliminates the objection, hearing, and appeal rights that have historically attached to termination decisions, and unlike federal contracts, it does not import the FAR's termination settlement framework. Multiyear grant recipients now bear contract-level cancellation risk without contract-level settlement protection.
Read article